Dr. Gamper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 North Wolfe Street
Rubenstein BLDG Lower Level
Baltimore, MD 21287Phone+1 443-997-5437Fax+1 410-367-2748
Education & Training
- Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2004 - 2007
- Johns Hopkins UniversityResidency, Pediatrics, 2001 - 2004
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2001
Certifications & Licensure
- MD State Medical License 2004 - 2026
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies Start of enrollment: 2015 Jul 02
Publications & Presentations
PubMed
- 21 citationsTRAF-3 interacts with p62 nucleoporin, a component of the nuclear pore central plug that binds classical NLS-containing import complexesC.J Gamper, W.G van Eyndhoven, E Schweiger, M Mossbacher, B Koo
Molecular Immunology. 2000-01-01 - 323 citationsHLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.Javier Bolaños-Meade, Ephraim J. Fuchs, Leo Luznik, Sophie Lanzkron, Christopher Gamper
Blood. 2012-11-22 - 36 citationsAll PI3Kinase signaling is not mTOR: dissecting mTOR-dependent and independent signaling pathways in T cells.Christopher Gamper, Jonathan D. Powell
Frontiers in Immunology. 2012-10-09
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/christopher-gamper
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: